Jaume Ferrer

2.3k total citations
62 papers, 1.6k citations indexed

About

Jaume Ferrer is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jaume Ferrer has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 16 papers in Physiology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jaume Ferrer's work include Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers), Occupational and environmental lung diseases (14 papers) and Respiratory Support and Mechanisms (13 papers). Jaume Ferrer is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers), Occupational and environmental lung diseases (14 papers) and Respiratory Support and Mechanisms (13 papers). Jaume Ferrer collaborates with scholars based in Spain, France and United States. Jaume Ferrer's co-authors include Judith García‐Aymerich, Marta Benet, Esther Rodríguez, Joaquim Gea, Àlvar Agustí, Ramón Orriols, Josep M. Antó, Jordi de Batlle, Jaume Sauleda and Ferrán Morell and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Cancer.

In The Last Decade

Jaume Ferrer

56 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaume Ferrer Spain 20 1.2k 453 158 153 139 62 1.6k
Ana MB Menezes Brazil 3 1.4k 1.2× 562 1.2× 133 0.8× 188 1.2× 91 0.7× 3 1.6k
S K Jindal India 25 1.0k 0.8× 759 1.7× 168 1.1× 229 1.5× 136 1.0× 55 2.1k
Md Mahmudur Rahman Siddiqui Bangladesh 5 1.3k 1.1× 545 1.2× 52 0.3× 168 1.1× 115 0.8× 27 1.5k
Md Mostafizur Rahman Bangladesh 4 1.3k 1.1× 544 1.2× 52 0.3× 163 1.1× 111 0.8× 13 1.5k
Anant Patel United Kingdom 17 1.1k 0.9× 455 1.0× 55 0.3× 224 1.5× 151 1.1× 45 1.4k
Martine Hoogendoorn Netherlands 20 948 0.8× 485 1.1× 42 0.3× 186 1.2× 88 0.6× 64 1.5k
J. Belda Spain 20 1.3k 1.1× 807 1.8× 59 0.4× 115 0.8× 152 1.1× 96 1.9k
Janwillem Kocks Netherlands 26 1.8k 1.4× 1.3k 2.8× 76 0.5× 199 1.3× 77 0.6× 141 2.6k
Marta Benet Spain 18 1.9k 1.6× 928 2.0× 177 1.1× 190 1.2× 287 2.1× 30 2.3k
Truls Sylvan Ingebrigtsen Denmark 22 1.5k 1.2× 739 1.6× 73 0.5× 184 1.2× 118 0.8× 42 1.8k

Countries citing papers authored by Jaume Ferrer

Since Specialization
Citations

This map shows the geographic impact of Jaume Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Ferrer more than expected).

Fields of papers citing papers by Jaume Ferrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Ferrer. The network helps show where Jaume Ferrer may publish in the future.

Co-authorship network of co-authors of Jaume Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Ferrer. A scholar is included among the top collaborators of Jaume Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Ferrer. Jaume Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cruz, María Jesús, et al.. (2023). Biomarker Profiles Associated with COVID-19 Severity and Mortality. Current Issues in Molecular Biology. 45(3). 1998–2012. 4 indexed citations
2.
Rodríguez, Esther, et al.. (2022). Promotion of physical activity after hospitalization for COPD exacerbation: A randomized control trial. Respirology. 28(4). 357–365. 14 indexed citations
3.
Sáez, María, Sergi Martí, Mercedes Pallero, et al.. (2022). Impact of home CPAP-treated obstructive sleep apnea on COVID-19 outcomes in hospitalized patients. Journal of Clinical Sleep Medicine. 18(7). 1857–1864. 8 indexed citations
4.
Ramón, María Antonia, Gerben ter Riet, Anne‐Elie Carsin, et al.. (2018). The dyspnoea–inactivity vicious circle in COPD: development and external validation of a conceptual model. European Respiratory Journal. 52(3). 1800079–1800079. 105 indexed citations
5.
Balcells, Eva, Elena Gimeno‐Santos, Jordi de Batlle, et al.. (2015). Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation. BMC Pulmonary Medicine. 15(1). 4–4. 19 indexed citations
6.
Dadvand, Payam, Mark Nieuwenhuijsen, Àlvar Agustí, et al.. (2014). Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients. European Respiratory Journal. 44(3). 603–613. 98 indexed citations
8.
Caparrós, Beatriz, et al.. (2011). Estilos comunicativos, vinculación universitaria y adaptación psicosocial.. Revista de investigación educativa, RIE. 29(2). 387–405. 3 indexed citations
9.
Cruz, María Jesús, et al.. (2011). Intrapulmonary asbestos concentrations in shipyard workers exposed to asbestos in El Ferrol, Spain. European Respiratory Journal. 38(Suppl 55). p1069–p1069. 1 indexed citations
10.
Martí, Sergi, Mercedes Pallero, Jaume Ferrer, et al.. (2010). Predictors of mortality in chest wall disease treated with noninvasive home mechanical ventilation. Respiratory Medicine. 104(12). 1843–1849. 17 indexed citations
11.
García‐Aymerich, Judith, Marta Benet, Eva Farrero, et al.. (2010). Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax. 66(5). 430–437. 231 indexed citations
12.
Balcells, Eva, Josep M. Antó, Joaquim Gea, et al.. (2009). Characteristics of patients admitted for the first time for COPD exacerbation. Respiratory Medicine. 103(9). 1293–1302. 53 indexed citations
13.
Ferrer, Jaume, et al.. (2007). Integration : the key to global success. Supply chain management review. 11(2). 8 indexed citations
14.
Viñas, Ferrán, et al.. (2004). DIMENSIONES PSICOPATOLÓGICAS ASOCIADAS AL CONSUMO DE TABACO EN POBLACIÓN UNIVERSITARIA. Anales de Psicología. 20(1). 33–46. 12 indexed citations
15.
Viñas, Ferrán, et al.. (2002). Internet y psicopatología: las nuevas formas de comunicación y su relación con diferentes índices de psicopatología. SHILAP Revista de lepidopterología. 23 indexed citations
17.
Ferrer, Jaume. (1995). El destinatari de l'Epístola 6, 31 de plini. 175–184.
18.
Ferrer, Jaume. (1994). Els oculacis d'Ebusus (a propòsit de nous testimonis). 201–211. 1 indexed citations
19.
Ferrer, Jaume, et al.. (1994). Energy-Dispersive X-Ray Analysis and Scanning Electron Microscopy of Pleura. Study of Reference, Exposed Non-Pneumoconiotic, and Silicotic Populations. American Journal of Respiratory and Critical Care Medicine. 149(4). 888–892. 12 indexed citations
20.
Ferrer, Jaume. (1988). Epigrafía romana de Ebusus. 1–118. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026